Boehringer forges $7bn alliance with China's SBP Group
Boehringer Ingelheim is paying $358m upfront for options on up to six antibody-drug conjugates and T-cell engagers from China's Sino Biopharma.
Why the best CROs challenge the trial plan and keep challeng...
Too often, oncology trials fail for reasons that could have been anticipated and addressed.
AI is exposing a new digital maturity divide in pharma busin...
As AI adoption increases, it is exposing just how prepared organisations really are to operate in a digitally connected environment.
Oral Wegovy bolsters Novo in Q3
Novo has raised its financial guidance for 2026 on the back of rising sales of its oral weight-loss therapy Wegovy.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
LEAP HR: Life Sciences Europe
Europe’s Only Industry-Specific Meeting Advancing HR Excellence in Life Sciences
Rational Based Drug Design Summit Europe
Driving Safer, Faster & More Efficient Discovery Across Europe
Evolution Summit 2027 to Convene Senior Clinical Development...
Westlake Village, CA: Marcus Evans today announced the Evolution Summit 2027, an invitation-only gathering of senior clinical trial executives
ISMAI 2026: Florence to host international symposium on the ...
On 3 and 4 December, in the CTO Auditorium of Careggi University Hospital, clinicians, scientists and international experts will discuss clinical judgement, patient safety and professional acco
11th Liquid Biopsy for Precision Oncology Summit West Coast
Your industry-leading, flagship West Coast meeting uniting the global liquid biopsy community